Nifty

:

22912.40

Sensex

:

74068.45

399.75 (1.78%)
1372.06 (1.89%)

Login

Nifty
Sensex

:
:

22912.40
74068.45

399.75 (1.78%)
1372.06 (1.89%)

Godavari Drugs Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 530317 | NSE: Not Listed

Watchlist

NSE BSE

87.39

24-Mar-2026

Open
High
Low
Previous Close

85.97
89.5
84
86.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8393
723925
89.5
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

88.50
23.97
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

160.14
N/A
1.82

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.77
-1.57
-10.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.17
3.75
3.58

PAT CAGR (%)

10 Years
5 Years
3 Years

12.49
1.18
4.94

P:E (Median)

8 Years
5 Years
3 Years

13.89
14.17
16.45

P:BV (Average)

8 Years
5 Years
3 Years

1.72
1.85
1.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.75
8.57
9.63

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 22.18 29.55 -24.94% 26.65 26.09 2.15% 23.81 32.21 -26.08% 25.50 38.64 -34.01%
Expenses 19.71 26.98 -26.95% 24.65 23.18 6.34% 20.91 28.98 -27.85% 22.39 34.17 -34.47%
EBITDA 2.48 2.58 -3.88% 2.00 2.91 -31.27% 2.90 3.23 -10.22% 3.11 4.47 -30.43%
EBIDTM 11.17% 8.72% 7.50% 11.14% 12.18% 10.04% 12.21% 11.58%
Other Income 0.02 0.10 -80.00% 0.64 0.01 6,300.00% 0.01 0.77 -98.70% 0.11 0.11 0.00%
Interest 1.11 1.11 0.00% 0.91 1.08 -15.74% 1.01 1.44 -29.86% 1.11 1.23 -9.76%
Depreciation 0.61 0.64 -4.69% 0.60 0.58 3.45% 0.60 0.55 9.09% 0.67 0.53 26.42%
PBT 1.02 0.92 10.87% 1.12 1.25 -10.40% 1.30 2.01 -35.32% 1.44 2.79 -48.39%
Tax 0.26 0.15 73.33% 0.12 0.16 -25.00% 0.26 0.38 -31.58% 0.55 0.13 323.08%
PAT 0.76 0.77 -1.30% 1.00 1.09 -8.26% 1.04 1.63 -36.20% 0.89 2.66 -66.54%
PATM 3.42% 2.60% 3.75% 4.17% 4.37% 5.07% 3.50% 6.89%
EPS 1.01 1.02 -0.98% 1.33 1.45 -8.28% 1.39 2.18 -36.24% 1.19 3.55 -66.48%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 98.14 113.35 156.71 159.62 161.11 122.67 95.70 83.54 64.45 75.60 71.12 Net Sales Growth -22.41% -27.67% -1.82% -0.92% 31.34% 28.18% 14.56% 29.62% -14.75% 6.30% Cost Of Goods Sold 69.71 81.66 120.81 128.06 130.45 96.59 76.67 64.91 49.27 58.94 58.68 Gross Profit 28.43 31.69 35.90 31.57 30.65 26.08 19.03 18.63 15.18 16.66 12.44 GP Margin 28.96% 27.96% 22.91% 19.78% 19.02% 21.26% 19.89% 22.30% 23.55% 22.04% 17.49% Total Expenditure 87.66 101.52 143.41 149.70 149.82 112.83 89.66 78.06 60.39 70.37 66.63 Power & Fuel Cost - 6.92 8.51 6.66 5.46 4.76 4.84 4.20 3.98 4.57 2.71 % Of Sales - 6.10% 5.43% 4.17% 3.39% 3.88% 5.06% 5.03% 6.18% 6.04% 3.81% Employee Cost - 5.03 5.13 4.84 4.96 3.94 3.45 3.45 2.67 2.38 2.17 % Of Sales - 4.44% 3.27% 3.03% 3.08% 3.21% 3.61% 4.13% 4.14% 3.15% 3.05% Manufacturing Exp. - 3.42 3.40 3.55 4.43 3.41 1.26 1.81 1.40 2.11 1.23 % Of Sales - 3.02% 2.17% 2.22% 2.75% 2.78% 1.32% 2.17% 2.17% 2.79% 1.73% General & Admin Exp. - 0.99 0.86 0.83 0.71 0.67 0.76 0.41 0.52 0.51 0.52 % Of Sales - 0.87% 0.55% 0.52% 0.44% 0.55% 0.79% 0.49% 0.81% 0.67% 0.73% Selling & Distn. Exp. - 0.23 0.31 0.17 0.38 0.30 0.28 0.18 0.15 0.20 0.19 % Of Sales - 0.20% 0.20% 0.11% 0.24% 0.24% 0.29% 0.22% 0.23% 0.26% 0.27% Miscellaneous Exp. - 3.27 4.38 5.60 3.42 3.16 2.40 3.09 2.39 1.67 0.19 % Of Sales - 2.88% 2.79% 3.51% 2.12% 2.58% 2.51% 3.70% 3.71% 2.21% 1.60% EBITDA 10.49 11.83 13.30 9.92 11.29 9.84 6.04 5.48 4.06 5.23 4.49 EBITDA Margin 10.69% 10.44% 8.49% 6.21% 7.01% 8.02% 6.31% 6.56% 6.30% 6.92% 6.31% Other Income 0.78 0.98 0.62 0.66 0.28 0.41 0.33 0.24 0.68 0.80 0.19 Interest 4.14 4.73 4.92 3.93 2.85 3.32 2.91 2.90 2.44 2.52 1.88 Depreciation 2.48 2.45 1.99 1.94 1.70 1.22 1.16 1.09 0.99 0.81 0.63 PBT 4.88 5.63 7.01 4.71 7.02 5.71 2.29 1.75 1.31 2.71 2.18 Tax 1.19 1.25 1.37 1.15 1.78 1.58 0.29 0.54 0.48 0.90 0.83 Tax Rate 24.39% 22.20% 19.80% 23.28% 25.36% 27.67% 12.66% 30.86% 36.64% 33.21% 38.07% PAT 3.69 4.38 5.55 3.79 5.25 4.13 2.00 1.21 0.83 1.81 1.35 PAT before Minority Interest 3.69 4.38 5.55 3.79 5.25 4.13 2.00 1.21 0.83 1.81 1.35 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.76% 3.86% 3.54% 2.37% 3.26% 3.37% 2.09% 1.45% 1.29% 2.39% 1.90% PAT Growth -40.00% -21.08% 46.44% -27.81% 27.12% 106.50% 65.29% 45.78% -54.14% 34.07% EPS 4.92 5.84 7.40 5.05 7.00 5.51 2.67 1.61 1.11 2.41 1.80

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 43.35 38.97 33.42 29.63 24.39 20.26 18.26 17.05 16.22 14.41 Share Capital 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 Total Reserves 35.82 31.44 25.89 22.10 16.86 12.73 10.73 9.52 8.69 6.88 Non-Current Liabilities 26.64 13.79 14.31 14.02 16.24 12.41 9.26 8.57 5.98 5.06 Secured Loans 12.13 3.31 4.93 4.51 7.23 4.66 3.68 2.02 0.09 0.13 Unsecured Loans 11.77 7.86 7.02 7.27 7.26 6.50 4.33 4.58 4.30 3.79 Long Term Provisions 0.83 0.76 0.71 0.72 0.79 0.67 0.57 0.55 0.39 0.33 Current Liabilities 73.09 82.00 73.71 57.76 50.51 51.25 46.22 37.41 33.50 31.07 Trade Payables 28.71 31.63 24.67 43.32 29.50 30.27 30.36 23.02 20.06 17.36 Other Current Liabilities 5.46 4.76 4.99 4.66 6.23 5.67 2.49 2.58 2.02 2.13 Short Term Borrowings 37.73 44.46 43.02 8.56 13.59 14.91 13.00 11.54 11.33 11.56 Short Term Provisions 1.19 1.16 1.02 1.23 1.19 0.39 0.36 0.27 0.09 0.02 Total Liabilities 143.08 134.76 121.44 101.41 91.14 83.92 73.74 63.03 55.70 50.54 Net Block 32.61 26.68 24.91 26.25 22.43 13.81 14.97 14.56 12.77 8.73 Gross Block 49.43 46.88 46.28 49.57 44.05 34.21 34.20 32.70 29.93 25.08 Accumulated Depreciation 16.82 20.19 21.37 23.32 21.62 20.40 19.23 18.15 17.16 16.35 Non Current Assets 64.31 46.27 34.43 27.08 23.53 23.09 17.24 15.73 13.07 10.15 Capital Work in Progress 29.95 18.32 9.08 0.49 0.76 8.93 2.05 0.97 0.12 1.20 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.65 1.15 0.34 0.23 0.33 0.35 0.23 0.21 0.19 0.22 Other Non Current Assets 0.11 0.11 0.10 0.10 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 78.76 88.48 87.01 74.33 67.61 60.83 56.49 47.29 42.63 40.40 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 27.94 20.65 19.86 10.03 14.65 17.75 16.47 13.47 11.32 10.74 Sundry Debtors 42.32 59.42 57.93 55.58 45.12 36.02 33.96 26.78 24.17 24.55 Cash & Bank 2.37 2.62 3.08 2.28 1.64 1.43 1.53 1.62 0.88 0.65 Other Current Assets 6.13 0.29 0.29 0.24 6.21 5.63 4.55 5.42 6.25 4.45 Short Term Loans & Adv. 4.39 5.49 5.84 6.20 5.90 5.20 4.28 5.25 2.08 1.52 Net Current Assets 5.67 6.48 13.30 16.57 17.10 9.58 10.28 9.88 9.13 9.32 Total Assets 143.07 134.75 121.44 101.41 91.14 83.92 73.73 63.02 55.70 50.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 11.20 18.41 13.22 11.23 1.33 6.24 3.71 3.82 5.15 -4.53 PBT 5.63 6.92 4.93 7.02 5.69 6.36 5.72 4.72 2.71 1.35 Adjustment 6.20 6.29 5.22 4.27 4.13 -0.33 -0.24 -0.68 2.51 0.56 Changes in Working Capital 0.52 6.22 4.29 1.72 -6.92 0.60 -1.49 0.35 0.43 -5.66 Cash after chg. in Working capital 12.35 19.43 14.44 13.01 2.91 6.63 3.99 4.39 5.65 -3.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.16 -1.02 -1.23 -1.78 -1.58 -0.39 -0.28 -0.57 -0.50 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.78 Cash From Investing Activity -19.51 -13.22 -8.64 -4.97 -1.25 -6.68 -2.34 -2.95 -2.97 -2.08 Net Fixed Assets -14.18 -9.84 -5.30 -5.25 -1.67 -6.89 -2.58 -3.62 -3.77 -2.75 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -5.33 -3.38 -3.34 0.28 0.42 0.21 0.24 0.67 0.80 0.67 Cash from Financing Activity 8.07 -5.65 -3.77 -5.62 0.13 0.34 -1.46 -0.14 -1.95 6.99 Net Cash Inflow / Outflow -0.25 -0.46 0.81 0.64 0.21 -0.10 -0.09 0.73 0.23 0.39 Opening Cash & Equivalents 2.62 3.08 2.28 1.64 1.43 1.53 1.62 0.88 0.65 0.26 Closing Cash & Equivalent 2.37 2.62 3.08 2.28 1.64 1.43 1.53 1.62 0.88 0.65

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 57.56 51.74 44.38 39.35 32.38 26.90 24.24 22.64 21.54 19.14 ROA 3.15% 4.33% 3.40% 5.45% 4.72% 2.54% 1.77% 1.40% 3.41% 3.17% ROE 10.64% 15.33% 12.01% 19.42% 18.49% 10.39% 6.85% 4.99% 11.81% 9.84% ROCE 10.13% 12.63% 12.36% 18.35% 17.58% 11.80% 12.14% 11.01% 16.89% 15.77% Fixed Asset Turnover 2.35 3.36 3.33 3.44 3.13 2.80 2.50 2.06 3.01 3.29 Receivable days 163.82 136.67 129.78 114.07 120.71 133.44 132.67 144.27 107.28 86.78 Inventory Days 78.24 47.17 34.17 27.96 48.21 65.26 65.40 70.21 48.60 46.13 Payable days 134.84 85.05 96.89 101.87 112.95 144.33 126.35 136.13 96.09 74.44 Cash Conversion Cycle 107.21 98.79 67.06 40.16 55.97 54.37 71.71 78.35 59.79 58.47 Total Debt/Equity 1.48 1.48 1.72 0.78 1.25 1.36 1.21 1.12 0.97 1.08 Interest Cover 2.19 2.41 2.26 3.46 2.72 1.79 1.60 1.54 2.08 2.16

Top Investors:

highcrestt global company ltd

umesh kumar gupta

gautam chand jain

swet realtors pvt. ltd

gopalakrishnan. v.

Annual Reports:

News Update:

Godavari Drugs - Quarterly Results
12th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback